tc-99m-mag3
Small moleculeexperimentalImaging agent
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Aug 1, 2017 (NCT03107286)
Timeline
No events for the selected filters.
Indications
Approved for
Studied for
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 99-technetium
Oral
No
Parenteral
No
Topical
No
Also known as
- tc-99m-mag3
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03107286 | Phase 4 | Aug 1, 2017 | Harvard University, Johns Hopkins University, National Institutes of Health (NIH), University of Florida |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Harvard University | Academic/Hospital | 1 | 1 | 1 | 2017 |
| Johns Hopkins University | Academic/Hospital | 1 | 0 | 1 | 2017 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2017 |
| University of Florida | Academic/Hospital | 1 | 0 | 1 | 2017 |
4 organizations
Page 1 / 1